{
    "title": "'Eureka moment' for cancer as the FDA approves first drug to target a tumor's genetic traits, rather than body parts",
    "url": "https://www.dailymail.co.uk/health/article-4538156/FDA-approves-drug-target-tumor-s-genetic-traits.html",
    "date": "2017-05-24",
    "keywords": [
        "cancer",
        "approval",
        "treatment",
        "drug",
        "body",
        "fda",
        "lung",
        "disease",
        "co",
        "form",
        "immunotherapy",
        "msih",
        "breast",
        "bladder",
        "head",
        "dr",
        "director",
        "johns",
        "share",
        "lot",
        "something",
        "year",
        "part",
        "move",
        "breakthrough",
        "future",
        "careit",
        "care",
        "lifeline",
        "mainline",
        "biomarker",
        "repair",
        "prostate",
        "gland",
        "partuntil",
        "example",
        "richard",
        "pazdur",
        "oncology",
        "center",
        "evaluation",
        "research",
        "tumor",
        "surgery",
        "dmmr",
        "institute",
        "trial",
        "marriage",
        "defect",
        "abundance",
        "mother",
        "internet",
        "donor",
        "flu",
        "jab",
        "article",
        "class",
        "pd1",
        "mechanism",
        "detection",
        "variety",
        "cancersthis",
        "pardoll",
        "interviewhe",
        "percent",
        "chemotherapythe",
        "benefit",
        "merck",
        "benefitthe",
        "position",
        "field",
        "immune",
        "system",
        "mantle",
        "keytruda",
        "survival",
        "nonsmall",
        "cell",
        "nsclckeytruda",
        "melanoma",
        "neck",
        "hodgkin",
        "lymphoma",
        "week",
        "decision"
    ],
    "category": [
        "health"
    ]
}